riesgo para cáncer de mama | sciencenewsnet.in

Breaking News

Could the liver hold the key to better cancer treatments?

Study opens new avenue for immunotherapy drug development

New York State, City and Bronx Borough Officials Celebrate the 125th Anniversary of the Bronx Zoo

Silent flight edges closer to take off, according to new research

A Common Pathway in the Brain That Enables Addictive Drugs to Hijack Natural Reward Processing Has Been Identified by Mount Sinai

Novel material supercharges innovation in electrostatic energy storage

MSU expert to attend oral arguments in SCOTUS case that could turn homelessness into a crime

New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies

Dana-Farber Chief Scientific Officer, Kevin Haigis, PhD, elected as Fellow of the American Association for the Advancement of Science

Hubble Goes Hunting for Small Main Belt Asteroids

19 Apr, 2024

Investigadores de Mayo Clinic crean prueba para medir efecto de variantes genéticas del cáncer de mama

February 25, 2021 sarah JonasResearch Results

Los investigadores de Mayo Clinic combinaron los resultados de una prueba funcional que mide el efecto de las variantes heredadas en el gen BRCA2 del cáncer de mama y ovario con la información clínica de mujeres sometidas a pruebas genéticas a fin de determinar la importancia clínica para el BRCA2 de muchas variantes de significado desconocido (VUS, por sus siglas en inglés).